Abstract Submission
It is expected that the abstract will include original data that
were not previously published in a peer-review journal or
the proceedings of a large national meeting.
Abstracts do not have to fit within the topics of the
plenary sessions to be accepted for presentation.
Abstract submission closes on April 30, 2008. In order to be considered for an oral presentation, abstracts should be submitted before April 1, 2008. It is understood that abstracts not selected for an oral presentation will be presented as a poster. Receipt of abstracts will be confirmed by e-mail latest by May 1st, 2008. If you have not received a confirmation by that date, please contact Prof. Michael Maragoudakis (maragoud@med.upatras.gr)
Acceptance of abstracts for oral presentation will
be announced by May 10, 2008.
The Conference Chairpersons/Scientific Advisory Committee
(SAC) will evaluate the scientific quality of the submitted
abstracts on the basis of the following criteria: novelty of
the research, significance of the findings and clarity.
Authors should be particularly cognizant of the importance
of setting forth the objectives and hypotheses of the study
in a clear, succinct manner and of summarizing the new,
unpublished results. If the abstract is poorly written such
that the reviewers cannot determine its novelty and
importance, it cannot be accepted for presentation. The
Conference Chairpersons/SAC have the right of the final
decision on all abstract presentations. Only those abstracts
that have been reviewed and accepted will be presented.
Accepted abstracts will be published in a hard-copy volume to be distributed at the meeting, if the presenting author is registered for the meeting. Each registration can support the submission of only one abstract.
Instructions for Typing of AbstractAbstracts should contain title, authors (with full names), affiliations and a summary of the work. References and acknowledgments can be included if required.
Titles should be indicative of the content of the abstract. All words necessary to identify the subject matter should be included in the title. Avoid non-standard abbreviations in abstract titles.
Type the title of abstract in capital letters, followed by the names of the authors and their affiliations.
Underline the name of presenting author ("The Presenter")
The combined length of the abstract title, list of authors, and body should not exceed 440 words. Tables and figures may be included.
Use font Times New Roman (except for special characters), size 11, single space, standard abbreviations.
Non-standard abbreviations may be used in the body of an abstract if they are defined at their first mention in the text.
Do not leave blank lines.
Use generic names of drugs. Complex therapeutic regimens must be defined.
Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting.
Authors are strongly encouraged to print a hard copy of their abstract for their records before submitting.
Save the abstract on your computer as a doc file using the last name of the presenting author as filename (e.g. Smith.doc).
Posters (Guidelines)
The posters submitted will be on exhibit during
the entire meeting. Authors should be present
during the guide poster viewing. Please note that the
maximum poster size is 0.90x1.5 m.
One page abstract should be written in English.
Head line: Bold, all caps, times new roman 14 pts
First names of authors must be in initials and
the last names in full. Presenting author
will be indicated by an asterisk (*).
Please include the affiliation and address
of the presenting author in times new roman 12 pts,
light grouped style, single spacing
The type areas have to be 16x25 cm. Please use times
new roman font, size 12 pts for the main text with 1 1/2
line spacing. The abstracts will be reduced in
size and printed in black and white. Figures
photographs and all descriptions must allow for
such reproduction.